Sanofi India · NSE: SANOFI · BSE: 500674
Q2 FY26 results · Jul–Sep 2025
Sanofi India reported revenue from operations of ₹475.40 crore (down 9.3% from Q2 FY25) and net profit of ₹76.00 crore (down 7.5% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a standalone basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 475.40 | 524.00 | −9.3% | 406.30 | +17.0% |
| Other income | 4.90 | 2.30 | +113.0% | 8.70 | −43.7% |
| Total income | 480.30 | 526.30 | −8.7% | 415.00 | +15.7% |
| Profit before tax | 102.30 | 112.59 | −9.1% | 94.10 | +8.7% |
| Net profit for the period | 76.00 | 82.19 | −7.5% | 69.50 | +9.4% |
| EPS, basic (₹) | 32.99 | 35.69 | −7.6% | 30.18 | +9.3% |
| Net margin (%) | 16.0 | 15.7 | 17.1 |
Standalone
- Filed with BSE
- 29 Oct 2025, 15:44 IST
- Board meeting
- 29 Oct 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE